There were 1,297 press releases posted in the last 24 hours and 438,428 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Intra-Cellular Therapies Announces FDA Acceptance of CAPLYTA® (lumateperone) sNDAs for the Treatment of Bipolar Depression

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image